Skip to main content
Top
Published in: American Journal of Clinical Dermatology 4/2017

01-08-2017 | Review Article

Cutaneous Manifestations of Diabetes Mellitus: A Review

Authors: Ana Luiza Lima, Tanja Illing, Sibylle Schliemann, Peter Elsner

Published in: American Journal of Clinical Dermatology | Issue 4/2017

Login to get access

Abstract

Diabetes mellitus is a widespread endocrine disease with severe impact on health systems worldwide. Increased serum glucose causes damage to a wide range of cell types, including endothelial cells, neurons, and renal cells, but also keratinocytes and fibroblasts. Skin disorders can be found in about one third of all people with diabetes and frequently occur before the diagnosis, thus playing an important role in the initial recognition of underlying disease. Noninfectious as well as infectious diseases have been described as dermatologic manifestations of diabetes mellitus. Moreover, diabetic neuropathy and angiopathy may also affect the skin. Pruritus, necrobiosis lipoidica, scleredema adultorum of Buschke, and granuloma annulare are examples of frequent noninfectious skin diseases. Bacterial and fungal skin infections are more frequent in people with diabetes. Diabetic neuropathy and angiopathy are responsible for diabetic foot syndrome and diabetic dermopathy. Furthermore, antidiabetic therapies may provoke dermatologic adverse events. Treatment with insulin may evoke local reactions like lipohypertrophy, lipoatrophy and both instant and delayed type allergy. Erythema multiforme, leukocytoclastic vasculitis, drug eruptions, and photosensitivity have been described as adverse reactions to oral antidiabetics. The identification of lesions may be crucial for the first diagnosis and for proper therapy of diabetes.
Literature
2.
go back to reference Perez MI, Kohn SR. Cutaneous manifestations of diabetes mellitus. J Am Acad Dermatol. 1994;30(4):519–31; quiz 32-4. Perez MI, Kohn SR. Cutaneous manifestations of diabetes mellitus. J Am Acad Dermatol. 1994;30(4):519–31; quiz 32-4.
5.
go back to reference American Diabetes A. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2004;27(Suppl 1):S5–10. American Diabetes A. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2004;27(Suppl 1):S5–10.
11.
go back to reference Jallut D, Golay A, Munger R, Frascarolo P, Schutz Y, Jequier E, et al. Impaired glucose tolerance and diabetes in obesity: a 6-year follow-up study of glucose metabolism. Metabolism. 1990;39(10):1068–75.PubMedCrossRef Jallut D, Golay A, Munger R, Frascarolo P, Schutz Y, Jequier E, et al. Impaired glucose tolerance and diabetes in obesity: a 6-year follow-up study of glucose metabolism. Metabolism. 1990;39(10):1068–75.PubMedCrossRef
12.
go back to reference Bastard JP, Maachi M, Lagathu C, Kim MJ, Caron M, Vidal H, et al. Recent advances in the relationship between obesity, inflammation, and insulin resistance. Eur Cytokine Netw. 2006;17(1):4–12.PubMed Bastard JP, Maachi M, Lagathu C, Kim MJ, Caron M, Vidal H, et al. Recent advances in the relationship between obesity, inflammation, and insulin resistance. Eur Cytokine Netw. 2006;17(1):4–12.PubMed
13.
go back to reference Metzger BE, Coustan DR. Summary and recommendations of the Fourth International Workshop-Conference on Gestational Diabetes Mellitus. The Organizing Committee. Diabetes Care. 1998;21(Suppl 2):B161–7.PubMed Metzger BE, Coustan DR. Summary and recommendations of the Fourth International Workshop-Conference on Gestational Diabetes Mellitus. The Organizing Committee. Diabetes Care. 1998;21(Suppl 2):B161–7.PubMed
14.
16.
go back to reference Catalano PM, Tyzbir ED, Wolfe RR, Calles J, Roman NM, Amini SB, et al. Carbohydrate metabolism during pregnancy in control subjects and women with gestational diabetes. Am J Physiol. 1993;264(1 Pt 1):E60–7.PubMed Catalano PM, Tyzbir ED, Wolfe RR, Calles J, Roman NM, Amini SB, et al. Carbohydrate metabolism during pregnancy in control subjects and women with gestational diabetes. Am J Physiol. 1993;264(1 Pt 1):E60–7.PubMed
20.
go back to reference WHO. Definition and diagnosis of diabetes mellitus and intermediate hyperglycemia: report of a WHO/IDF consultation. Geneva: WHO; 2006. WHO. Definition and diagnosis of diabetes mellitus and intermediate hyperglycemia: report of a WHO/IDF consultation. Geneva: WHO; 2006.
21.
go back to reference ADA. Standards of medical care in diabetes—2010. Diabetes Care. 2010;33(Suppl. 1):S11–61. ADA. Standards of medical care in diabetes—2010. Diabetes Care. 2010;33(Suppl. 1):S11–61.
22.
go back to reference Palimeri S, Palioura E, Diamanti-Kandarakis E. Current perspectives on the health risks associated with the consumption of advanced glycation end products: recommendations for dietary management. Diabetes Metab Syndr Obes. 2015;8:415–26. doi:10.2147/DMSO.S63089.PubMedPubMedCentral Palimeri S, Palioura E, Diamanti-Kandarakis E. Current perspectives on the health risks associated with the consumption of advanced glycation end products: recommendations for dietary management. Diabetes Metab Syndr Obes. 2015;8:415–26. doi:10.​2147/​DMSO.​S63089.PubMedPubMedCentral
25.
go back to reference Stern D, Yan SD, Yan SF, Schmidt AM. Receptor for advanced glycation endproducts: a multiligand receptor magnifying cell stress in diverse pathologic settings. Adv Drug Deliv Rev. 2002;54(12):1615–25.PubMedCrossRef Stern D, Yan SD, Yan SF, Schmidt AM. Receptor for advanced glycation endproducts: a multiligand receptor magnifying cell stress in diverse pathologic settings. Adv Drug Deliv Rev. 2002;54(12):1615–25.PubMedCrossRef
26.
28.
go back to reference Ko MJ, Chiu HC, Jee SH, Hu FC, Tseng CH. Postprandial blood glucose is associated with generalized pruritus in patients with type 2 diabetes. Eur J Dermatol. 2013;23(5):688–93. doi:10.1684/ejd.2013.2100.PubMed Ko MJ, Chiu HC, Jee SH, Hu FC, Tseng CH. Postprandial blood glucose is associated with generalized pruritus in patients with type 2 diabetes. Eur J Dermatol. 2013;23(5):688–93. doi:10.​1684/​ejd.​2013.​2100.PubMed
34.
go back to reference Zylicz Z, Krajnik M, Sorge AA, Costantini M. Paroxetine in the treatment of severe non-dermatological pruritus: a randomized, controlled trial. J Pain Symptom Manage. 2003;26(6):1105–12.PubMedCrossRef Zylicz Z, Krajnik M, Sorge AA, Costantini M. Paroxetine in the treatment of severe non-dermatological pruritus: a randomized, controlled trial. J Pain Symptom Manage. 2003;26(6):1105–12.PubMedCrossRef
36.
go back to reference Cohen O, Yaniv R, Karasik A, Trau H. Necrobiosis lipoidica and diabetic control revisited. Med Hypotheses. 1996;46(4):348–50.PubMedCrossRef Cohen O, Yaniv R, Karasik A, Trau H. Necrobiosis lipoidica and diabetic control revisited. Med Hypotheses. 1996;46(4):348–50.PubMedCrossRef
37.
39.
go back to reference Jiquan S, Khalaf AT, Jinquan T, Xiaoming L. Necrobiosis lipoidica: a case with histopathological findings revealed asteroid bodies and was successfully treated with dipyridamole plus intralesional triamcinolone. J Dermatol Treat. 2008;19(1):54–7. doi:10.1080/09546630701691228.CrossRef Jiquan S, Khalaf AT, Jinquan T, Xiaoming L. Necrobiosis lipoidica: a case with histopathological findings revealed asteroid bodies and was successfully treated with dipyridamole plus intralesional triamcinolone. J Dermatol Treat. 2008;19(1):54–7. doi:10.​1080/​0954663070169122​8.CrossRef
41.
go back to reference Suarez-Amor O, Perez-Bustillo A, Ruiz-Gonzalez I, Rodriguez-Prieto MA. Necrobiosis lipoidica therapy with biologicals: an ulcerated case responding to etanercept and a review of the literature. Dermatology. 2010;221(2):117–21. doi:10.1159/000314694.PubMed Suarez-Amor O, Perez-Bustillo A, Ruiz-Gonzalez I, Rodriguez-Prieto MA. Necrobiosis lipoidica therapy with biologicals: an ulcerated case responding to etanercept and a review of the literature. Dermatology. 2010;221(2):117–21. doi:10.​1159/​000314694.PubMed
44.
go back to reference Erfurt-Berge C, Seitz AT, Rehse C, Wollina U, Schwede K, Renner R. Update on clinical and laboratory features in necrobiosis lipoidica: a retrospective multicentre study of 52 patients. Eur J Dermatol. 2012;22(6):770–5. doi:10.1684/ejd.2012.1839.PubMed Erfurt-Berge C, Seitz AT, Rehse C, Wollina U, Schwede K, Renner R. Update on clinical and laboratory features in necrobiosis lipoidica: a retrospective multicentre study of 52 patients. Eur J Dermatol. 2012;22(6):770–5. doi:10.​1684/​ejd.​2012.​1839.PubMed
46.
go back to reference Angeli-Besson C, Koeppel MC, Jacquet P, Andrac L, Sayag J. Electron-beam therapy in scleredema adultorum with associated monoclonal hypergammaglobulinaemia. Br J Dermatol. 1994;130(3):394–7.PubMedCrossRef Angeli-Besson C, Koeppel MC, Jacquet P, Andrac L, Sayag J. Electron-beam therapy in scleredema adultorum with associated monoclonal hypergammaglobulinaemia. Br J Dermatol. 1994;130(3):394–7.PubMedCrossRef
47.
go back to reference Dinato SL, Costa GL, Dinato MC, Sementilli A, Romiti N. Scleredema of Buschke associated with diabetes mellitus type 2: case report and review of the literature. Arq Bras Endocrinol Metabol. 2010;54(9):852–5.PubMedCrossRef Dinato SL, Costa GL, Dinato MC, Sementilli A, Romiti N. Scleredema of Buschke associated with diabetes mellitus type 2: case report and review of the literature. Arq Bras Endocrinol Metabol. 2010;54(9):852–5.PubMedCrossRef
50.
go back to reference Aye M, Masson EA. Dermatological care of the diabetic foot. Am J Clin Dermatol. 2002;3(7):463–74.PubMedCrossRef Aye M, Masson EA. Dermatological care of the diabetic foot. Am J Clin Dermatol. 2002;3(7):463–74.PubMedCrossRef
51.
go back to reference Basarab T, Munn SE, McGrath J, Russell Jones R. Bullosis diabeticorum. A case report and literature review. Clin Exp Dermatol. 1995;20(3):218–20.PubMedCrossRef Basarab T, Munn SE, McGrath J, Russell Jones R. Bullosis diabeticorum. A case report and literature review. Clin Exp Dermatol. 1995;20(3):218–20.PubMedCrossRef
52.
go back to reference Nebesio CL, Lewis C, Chuang TY. Lack of an association between granuloma annulare and type 2 diabetes mellitus. Br J Dermatol. 2002;146(1):122–4.PubMedCrossRef Nebesio CL, Lewis C, Chuang TY. Lack of an association between granuloma annulare and type 2 diabetes mellitus. Br J Dermatol. 2002;146(1):122–4.PubMedCrossRef
53.
go back to reference Goucha S, Khaled A, Kharfi M, Fazaa B, Zermani R, Ben Jilani S, et al. Granuloma annulare. G Ital Dermatol Venereol. 2008;143(6):359–63.PubMed Goucha S, Khaled A, Kharfi M, Fazaa B, Zermani R, Ben Jilani S, et al. Granuloma annulare. G Ital Dermatol Venereol. 2008;143(6):359–63.PubMed
55.
go back to reference Li A, Hogan DJ, Sanusi ID, Smoller BR. Granuloma annulare and malignant neoplasms. Am J Dermatopathol. 2003;25(2):113–6.PubMedCrossRef Li A, Hogan DJ, Sanusi ID, Smoller BR. Granuloma annulare and malignant neoplasms. Am J Dermatopathol. 2003;25(2):113–6.PubMedCrossRef
57.
go back to reference Milicic V, Ravic-Nikolic A, Jovovic-Dagovic B, Ristic G, Mitrovic S. Generalized granuloma annulare presenting as arcuate dermal erythema. Acta Dermatovenerol Alp Pannonica Adriat. 2010;19(1):25–7.PubMed Milicic V, Ravic-Nikolic A, Jovovic-Dagovic B, Ristic G, Mitrovic S. Generalized granuloma annulare presenting as arcuate dermal erythema. Acta Dermatovenerol Alp Pannonica Adriat. 2010;19(1):25–7.PubMed
58.
go back to reference Rubel DM, Wood G, Rosen R, Jopp-McKay A. Generalised granuloma annulare successfully treated with pentoxifylline. Australas J Dermatol. 1993;34(3):103–8.PubMedCrossRef Rubel DM, Wood G, Rosen R, Jopp-McKay A. Generalised granuloma annulare successfully treated with pentoxifylline. Australas J Dermatol. 1993;34(3):103–8.PubMedCrossRef
59.
go back to reference Hermanns-Le T, Scheen A, Pierard GE. Acanthosis nigricans associated with insulin resistance: pathophysiology and management. Am J Clin Dermatol. 2004;5(3):199–203.PubMedCrossRef Hermanns-Le T, Scheen A, Pierard GE. Acanthosis nigricans associated with insulin resistance: pathophysiology and management. Am J Clin Dermatol. 2004;5(3):199–203.PubMedCrossRef
60.
go back to reference Stoddart ML, Blevins KS, Lee ET, Wang W, Blackett PR, Cherokee Diabetes S. Association of acanthosis nigricans with hyperinsulinemia compared with other selected risk factors for type 2 diabetes in Cherokee Indians: the Cherokee Diabetes Study. Diabetes Care. 2002;25(6):1009–14.PubMedCrossRef Stoddart ML, Blevins KS, Lee ET, Wang W, Blackett PR, Cherokee Diabetes S. Association of acanthosis nigricans with hyperinsulinemia compared with other selected risk factors for type 2 diabetes in Cherokee Indians: the Cherokee Diabetes Study. Diabetes Care. 2002;25(6):1009–14.PubMedCrossRef
62.
go back to reference Apridonidze T, Essah PA, Iuorno MJ, Nestler JE. Prevalence and characteristics of the metabolic syndrome in women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2005;90(4):1929–35. doi:10.1210/jc.2004-1045.PubMedCrossRef Apridonidze T, Essah PA, Iuorno MJ, Nestler JE. Prevalence and characteristics of the metabolic syndrome in women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2005;90(4):1929–35. doi:10.​1210/​jc.​2004-1045.PubMedCrossRef
65.
go back to reference Stals H, Vercammen C, Peeters C, Morren MA. Acanthosis nigricans caused by nicotinic acid: case report and review of the literature. Dermatology. 1994;189(2):203–6.PubMedCrossRef Stals H, Vercammen C, Peeters C, Morren MA. Acanthosis nigricans caused by nicotinic acid: case report and review of the literature. Dermatology. 1994;189(2):203–6.PubMedCrossRef
67.
go back to reference Amer AA, Gao XH. Quality of life in patients with vitiligo: an analysis of the dermatology life quality index outcome over the past two decades. Int J Dermatol. 2016;55(6):608–14. doi:10.1111/ijd.13198.PubMedCrossRef Amer AA, Gao XH. Quality of life in patients with vitiligo: an analysis of the dermatology life quality index outcome over the past two decades. Int J Dermatol. 2016;55(6):608–14. doi:10.​1111/​ijd.​13198.PubMedCrossRef
68.
go back to reference Martis J, Bhat R, Nandakishore B, Shetty JN. A clinical study of vitiligo. Indian J Dermatol Venereol Leprol. 2002;68(2):92–3.PubMed Martis J, Bhat R, Nandakishore B, Shetty JN. A clinical study of vitiligo. Indian J Dermatol Venereol Leprol. 2002;68(2):92–3.PubMed
69.
go back to reference Whitton M, Pinart M, Batchelor JM, Leonardi-Bee J, Gonzalez U, Jiyad Z, et al. Evidence-based management of vitiligo: summary of a Cochrane systematic review. Br J Dermatol. 2016;174(5):962–9. doi:10.1111/bjd.14356.PubMedCrossRef Whitton M, Pinart M, Batchelor JM, Leonardi-Bee J, Gonzalez U, Jiyad Z, et al. Evidence-based management of vitiligo: summary of a Cochrane systematic review. Br J Dermatol. 2016;174(5):962–9. doi:10.​1111/​bjd.​14356.PubMedCrossRef
71.
go back to reference Nikoleishvili LR, Kurashvili RB, Virsaladze DK, Khachapuridze NG, Kurashvili LR. Characteristic changes of skin and its accessories in type 2 diabetes mellitus. Georgian Med News. 2006;131:43–6. Nikoleishvili LR, Kurashvili RB, Virsaladze DK, Khachapuridze NG, Kurashvili LR. Characteristic changes of skin and its accessories in type 2 diabetes mellitus. Georgian Med News. 2006;131:43–6.
72.
go back to reference Suzuki K, Ito Y, Nakamura S, Ochiai J, Aoki K. Relationship between serum carotenoids and hyperglycemia: a population-based cross-sectional study. J Epidemiol. 2002;12(5):357–66.PubMedCrossRef Suzuki K, Ito Y, Nakamura S, Ochiai J, Aoki K. Relationship between serum carotenoids and hyperglycemia: a population-based cross-sectional study. J Epidemiol. 2002;12(5):357–66.PubMedCrossRef
75.
go back to reference Manousaridis I, Manousaridis K, Peitsch WK, Schneider SW. Individualizing treatment and choice of medication in lichen planus: a step by step approach. J Dtsch Dermatol Ges. 2013;11(10):981–91. doi:10.1111/ddg.12141.PubMed Manousaridis I, Manousaridis K, Peitsch WK, Schneider SW. Individualizing treatment and choice of medication in lichen planus: a step by step approach. J Dtsch Dermatol Ges. 2013;11(10):981–91. doi:10.​1111/​ddg.​12141.PubMed
79.
go back to reference Yancovitz M, Johnson H, Wang N, Pomeranz MK. Perforating collagenosis. Dermatol Online J. 2008;14(10):14.PubMed Yancovitz M, Johnson H, Wang N, Pomeranz MK. Perforating collagenosis. Dermatol Online J. 2008;14(10):14.PubMed
80.
go back to reference Nebel R, Fiedler E, Danz B, Marsch WC, Kreft B. Acquired reactive perforating collagenosis associated with diabetes mellitus and renal insufficiency requiring dialysis. Dtsch Med Wochenschr. 2007;132(49):2624–6. doi:10.1055/s-2007-993108.PubMedCrossRef Nebel R, Fiedler E, Danz B, Marsch WC, Kreft B. Acquired reactive perforating collagenosis associated with diabetes mellitus and renal insufficiency requiring dialysis. Dtsch Med Wochenschr. 2007;132(49):2624–6. doi:10.​1055/​s-2007-993108.PubMedCrossRef
86.
go back to reference American Diabetes A. Peripheral arterial disease in people with diabetes. Diabetes Care. 2003;26(12):3333–41.CrossRef American Diabetes A. Peripheral arterial disease in people with diabetes. Diabetes Care. 2003;26(12):3333–41.CrossRef
90.
go back to reference Perkins BA, Olaleye D, Bril V. Carpal tunnel syndrome in patients with diabetic polyneuropathy. Diabetes Care. 2002;25(3):565–9.PubMedCrossRef Perkins BA, Olaleye D, Bril V. Carpal tunnel syndrome in patients with diabetic polyneuropathy. Diabetes Care. 2002;25(3):565–9.PubMedCrossRef
95.
go back to reference Yosipovitch G, Tur E, Cohen O, Rusecki Y. Skin surface pH in intertriginous areas in NIDDM patients. Possible correlation to candidal intertrigo. Diabetes Care. 1993;16(4):560–3.PubMedCrossRef Yosipovitch G, Tur E, Cohen O, Rusecki Y. Skin surface pH in intertriginous areas in NIDDM patients. Possible correlation to candidal intertrigo. Diabetes Care. 1993;16(4):560–3.PubMedCrossRef
97.
go back to reference Sunderkotter C, Becker K. Frequent bacterial skin and soft tissue infections: diagnostic signs and treatment. J Dtsch Dermatol Ges. 2015;13(6):501–24; quiz 25-6. doi:10.1111/ddg.12721. Sunderkotter C, Becker K. Frequent bacterial skin and soft tissue infections: diagnostic signs and treatment. J Dtsch Dermatol Ges. 2015;13(6):501–24; quiz 25-6. doi:10.​1111/​ddg.​12721.
103.
go back to reference Wong CH, Chang HC, Pasupathy S, Khin LW, Tan JL, Low CO. Necrotizing fasciitis: clinical presentation, microbiology, and determinants of mortality. J Bone Jt Surg Am. 2003;85-A(8):1454–60.CrossRef Wong CH, Chang HC, Pasupathy S, Khin LW, Tan JL, Low CO. Necrotizing fasciitis: clinical presentation, microbiology, and determinants of mortality. J Bone Jt Surg Am. 2003;85-A(8):1454–60.CrossRef
105.
go back to reference Rubin Grandis J, Branstetter BFT, Yu VL. The changing face of malignant (necrotising) external otitis: clinical, radiological, and anatomic correlations. Lancet Infect Dis. 2004;4(1):34–9.PubMedCrossRef Rubin Grandis J, Branstetter BFT, Yu VL. The changing face of malignant (necrotising) external otitis: clinical, radiological, and anatomic correlations. Lancet Infect Dis. 2004;4(1):34–9.PubMedCrossRef
106.
go back to reference Gupta AK, Konnikov N, MacDonald P, Rich P, Rodger NW, Edmonds MW, et al. Prevalence and epidemiology of toenail onychomycosis in diabetic subjects: a multicentre survey. Br J Dermatol. 1998;139(4):665–71.PubMedCrossRef Gupta AK, Konnikov N, MacDonald P, Rich P, Rodger NW, Edmonds MW, et al. Prevalence and epidemiology of toenail onychomycosis in diabetic subjects: a multicentre survey. Br J Dermatol. 1998;139(4):665–71.PubMedCrossRef
107.
go back to reference Lugo-Somolinos A, Sanchez JL. Prevalence of dermatophytosis in patients with diabetes. J Am Acad Dermatol. 1992;26(3 Pt 2):408–10.PubMedCrossRef Lugo-Somolinos A, Sanchez JL. Prevalence of dermatophytosis in patients with diabetes. J Am Acad Dermatol. 1992;26(3 Pt 2):408–10.PubMedCrossRef
108.
go back to reference de Leon EM, Jacober SJ, Sobel JD, Foxman B. Prevalence and risk factors for vaginal Candida colonization in women with type 1 and type 2 diabetes. BMC Infect Dis. 2002;2:1.PubMedPubMedCentralCrossRef de Leon EM, Jacober SJ, Sobel JD, Foxman B. Prevalence and risk factors for vaginal Candida colonization in women with type 1 and type 2 diabetes. BMC Infect Dis. 2002;2:1.PubMedPubMedCentralCrossRef
110.
go back to reference Rashid M, Bari A, Majeed S, Tariq KM, Haq I, Niwaz A. Mucormycosis: a devastating fungal infection in diabetics. J Coll Physicians Surg Pak. 2005;15(1):43–5. doi:01.2005/JCPSP.4345. Rashid M, Bari A, Majeed S, Tariq KM, Haq I, Niwaz A. Mucormycosis: a devastating fungal infection in diabetics. J Coll Physicians Surg Pak. 2005;15(1):43–5. doi:01.2005/JCPSP.4345.
112.
go back to reference Prabhu RM, Patel R. Mucormycosis and entomophthoramycosis: a review of the clinical manifestations, diagnosis and treatment. Clin Microbiol Infect. 2004;10(Suppl 1):31–47.PubMedCrossRef Prabhu RM, Patel R. Mucormycosis and entomophthoramycosis: a review of the clinical manifestations, diagnosis and treatment. Clin Microbiol Infect. 2004;10(Suppl 1):31–47.PubMedCrossRef
113.
go back to reference Richardson T, Kerr D. Skin-related complications of insulin therapy: epidemiology and emerging management strategies. Am J Clin Dermatol. 2003;4(10):661–7.PubMedCrossRef Richardson T, Kerr D. Skin-related complications of insulin therapy: epidemiology and emerging management strategies. Am J Clin Dermatol. 2003;4(10):661–7.PubMedCrossRef
114.
go back to reference Young RJ, Hannan WJ, Frier BM, Steel JM, Duncan LJ. Diabetic lipohypertrophy delays insulin absorption. Diabetes Care. 1984;7(5):479–80.PubMedCrossRef Young RJ, Hannan WJ, Frier BM, Steel JM, Duncan LJ. Diabetic lipohypertrophy delays insulin absorption. Diabetes Care. 1984;7(5):479–80.PubMedCrossRef
115.
116.
go back to reference Beltrand J, Guilmin-Crepon S, Castanet M, Peuchmaur M, Czernichow P, Levy-Marchal C. Insulin allergy and extensive lipoatrophy in child with type 1 diabetes. Horm Res. 2006;65(5):253–60. doi:10.1159/000092515.PubMed Beltrand J, Guilmin-Crepon S, Castanet M, Peuchmaur M, Czernichow P, Levy-Marchal C. Insulin allergy and extensive lipoatrophy in child with type 1 diabetes. Horm Res. 2006;65(5):253–60. doi:10.​1159/​000092515.PubMed
117.
go back to reference Havel PJ. Update on adipocyte hormones: regulation of energy balance and carbohydrate/lipid metabolism. Diabetes. 2004;53(Suppl 1):S143–51.PubMedCrossRef Havel PJ. Update on adipocyte hormones: regulation of energy balance and carbohydrate/lipid metabolism. Diabetes. 2004;53(Suppl 1):S143–51.PubMedCrossRef
118.
go back to reference Radermecker RP, Pierard GE, Scheen AJ. Lipodystrophy reactions to insulin: effects of continuous insulin infusion and new insulin analogs. Am J Clin Dermatol. 2007;8(1):21–8.PubMedCrossRef Radermecker RP, Pierard GE, Scheen AJ. Lipodystrophy reactions to insulin: effects of continuous insulin infusion and new insulin analogs. Am J Clin Dermatol. 2007;8(1):21–8.PubMedCrossRef
119.
go back to reference Scheer BG, Sitz KV. Suspected insulin anaphylaxis and literature review. J Ark Med Soc. 2001;97(9):311–3.PubMed Scheer BG, Sitz KV. Suspected insulin anaphylaxis and literature review. J Ark Med Soc. 2001;97(9):311–3.PubMed
121.
go back to reference Blanco C, Castillo R, Quiralte J, Delgado J, Garcia I, de Pablos P, et al. Anaphylaxis to subcutaneous neutral protamine Hagedorn insulin with simultaneous sensitization to protamine and insulin. Allergy. 1996;51(6):421–4.PubMed Blanco C, Castillo R, Quiralte J, Delgado J, Garcia I, de Pablos P, et al. Anaphylaxis to subcutaneous neutral protamine Hagedorn insulin with simultaneous sensitization to protamine and insulin. Allergy. 1996;51(6):421–4.PubMed
122.
124.
go back to reference Fujii S, Nakashima T, Kaneko T. Glibenclamide-induced photosensitivity in a diabetic patient with erythropoietic protoporphyria. Am J Hematol. 1995;50(3):223.PubMedCrossRef Fujii S, Nakashima T, Kaneko T. Glibenclamide-induced photosensitivity in a diabetic patient with erythropoietic protoporphyria. Am J Hematol. 1995;50(3):223.PubMedCrossRef
125.
go back to reference Noakes R. Lichenoid drug eruption as a result of the recently released sulfonylurea glimepiride. Australas J Dermatol. 2003;44(4):302–3.PubMedCrossRef Noakes R. Lichenoid drug eruption as a result of the recently released sulfonylurea glimepiride. Australas J Dermatol. 2003;44(4):302–3.PubMedCrossRef
126.
go back to reference Lao B, Czyzyk A, Szutowski M, Szczepanik Z. Alcohol tolerance in patients with non-insulin-dependent (type 2) diabetes treated with sulphonylurea derivatives. Arzneimittelforschung. 1994;44(6):727–34.PubMed Lao B, Czyzyk A, Szutowski M, Szczepanik Z. Alcohol tolerance in patients with non-insulin-dependent (type 2) diabetes treated with sulphonylurea derivatives. Arzneimittelforschung. 1994;44(6):727–34.PubMed
127.
go back to reference Franz CB, Massullo RE, Welton WA. Lichenoid drug eruption from chlorpropamide and tolazamide. J Am Acad Dermatol. 1990;22(1):128–9.PubMedCrossRef Franz CB, Massullo RE, Welton WA. Lichenoid drug eruption from chlorpropamide and tolazamide. J Am Acad Dermatol. 1990;22(1):128–9.PubMedCrossRef
128.
129.
go back to reference Paterson AJ, Lamey PJ, Lewis MA, Nolan A, Rademaker M. Pemphigus vulgaris precipitated by glibenclamide therapy. J Oral Pathol Med. 1993;22(2):92–5.PubMedCrossRef Paterson AJ, Lamey PJ, Lewis MA, Nolan A, Rademaker M. Pemphigus vulgaris precipitated by glibenclamide therapy. J Oral Pathol Med. 1993;22(2):92–5.PubMedCrossRef
130.
go back to reference Goldberg I, Sasson A, Gat A, Srebrnik A, Brenner S. Pemphigus vulgaris triggered by glibenclamide and cilazapril. Acta Dermatovenerol Croat. 2005;13(3):153–5.PubMed Goldberg I, Sasson A, Gat A, Srebrnik A, Brenner S. Pemphigus vulgaris triggered by glibenclamide and cilazapril. Acta Dermatovenerol Croat. 2005;13(3):153–5.PubMed
131.
go back to reference Koca R, Altinyazar HC, Yenidunya S, Tekin NS. Psoriasiform drug eruption associated with metformin hydrochloride: a case report. Dermatol Online J. 2003;9(3):11.PubMed Koca R, Altinyazar HC, Yenidunya S, Tekin NS. Psoriasiform drug eruption associated with metformin hydrochloride: a case report. Dermatol Online J. 2003;9(3):11.PubMed
Metadata
Title
Cutaneous Manifestations of Diabetes Mellitus: A Review
Authors
Ana Luiza Lima
Tanja Illing
Sibylle Schliemann
Peter Elsner
Publication date
01-08-2017
Publisher
Springer International Publishing
Published in
American Journal of Clinical Dermatology / Issue 4/2017
Print ISSN: 1175-0561
Electronic ISSN: 1179-1888
DOI
https://doi.org/10.1007/s40257-017-0275-z

Other articles of this Issue 4/2017

American Journal of Clinical Dermatology 4/2017 Go to the issue